FDA NDC Directory · JSON-LD · Markdown

Nicotine Polacrilex

NDC 45802-089 · HUMAN OTC DRUG · LOZENGE

Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA203690
Dosage form / routeLOZENGE · ORAL
Active ingredientsNICOTINE (2 mg/1)
Marketing started20160708
Package count1

External sources

Source: openFDA. Public-domain (CC0).